$55 it is, page-14

The only thing that surprises me is that you got 1 x good analysis and two likes for a completely unsubstantiated out of the box “prediction” without any supporting facts !

I agree with royce... whats the basis and proof for your sweeping and dramatic prediction?

High PE companies have high built in expectations and any change in forecast earnings or profit forecasts will see short term investors “bailing out” and cutting their losses. I have held RHC from $6.20 and I can assure you that no relatively high PE stock like RHC, COH, or CSL which I also hold has gone up in a straight line. RHC I believe has been oversold short term, as it is still forecasting 7% earnings growth, not the 10% that they and others had hoped for. The new pharmaceutical joint venture is still in the embryo stage but has obvious potential.
There is one undeniable fact and that is that the worlds population is increasing. They are slowly becoming more affluent and nothing is going to change the fact that there are going to be more people in the future requiring medical attention and the way things are going, reduced government resources to be able to meet the demand both in Australia and Internationally.

Now I may be right and I may be wrong, but at least I have provided reasons for my assessment !

Are you in any way related to Henny Penny ?